Study advances cancer-killing cream for melanoma

October 10, 2012

(Medical Xpress)—RMIT University researchers have designed a peptide that imitates a melanoma-killing virus, in a biomedical engineering advance that could lead to the development of a cream to target and treat Australia's "national cancer".

The RMIT team has successfully synthesised a peptide that mimics the activity of a virus protein, with showing the peptide kills while leaving normal unharmed.

Lead investigator Dr Taghrid Istivan said peptide therapy had the potential to lead to new, non-invasive treatments for melanoma, which is responsible for 75 per cent of deaths in Australia.

"Australia has the highest incidence of melanoma in the world, with more than 11,000 new diagnoses each year," Dr Istivan said.

"Currently the only effective treatment for early stage melanoma is surgery to cut out the tumour and healthy skin surrounding the affected mole.

"The peptide we have developed is toxic to melanoma cells but leaves normal skin cells unaffected.

"With further work, including clinical trials, we hope our research could lead to the development of a cream to painlessly and efficiently treat early stage melanoma."

Dr Istivan and her colleagues in RMIT's Health Innovations Research Institute and the School of Applied Sciences tested the efficacy of a peptide - a short chain of - that was designed to work like the proteins of the myxoma virus, a cancer-killing virus shown to be toxic to melanoma in previous studies.

"A is big, expensive to synthesise and has inherent risks when used in medical treatments, because all viruses can mutate," she said.

"By synthesising a small peptide that mimics the action of a protein, we can offer a stable, safe, targeted and cost-effective alternative."

The researchers used a novel bioengineering method developed at RMIT by Professor Irena Cosic and Dr Elena Pirogova, from the School of Electrical and Computer Engineering, to design the peptide. The peptide was synthesised as a powder, liquefied and tested in vitro on normal human cells and cells.

Dr Istivan is presenting the research findings at the 40th Congress of the International Society of Oncology and Biomarkers (13 - 17 October, Jerusalem).

Explore further: Potential new treatment target identified for melanoma skin cancer

Related Stories

Potential new treatment target identified for melanoma skin cancer

August 15, 2012
New research from Western University, Canada, has identified a potential new target for the treatment of melanoma, the deadliest of all skin cancers. Silvia Penuela and Dale Laird discovered a new channel-forming protein ...

RNA spurs melanoma development

May 10, 2011
Traditionally, RNA was mostly known as the messenger molecule that carries protein-making instructions from a cell's nucleus to the cytoplasm. But scientists now estimate that approximately 97 percent of human RNA doesn't ...

Scientists find molecule in immune system that could help treat dangerous skin cancer

July 8, 2012
Researchers from Brigham and Women's Hospital (BWH) have made a groundbreaking discovery that will shape the future of melanoma therapy. The team, led by Thomas S. Kupper, MD, chair of the BWH Department of Dermatology, and ...

Recommended for you

Study provides insight into link between two rare tumor syndromes

August 22, 2017
UCLA researchers have discovered that timing is everything when it comes to preventing a specific gene mutation in mice from developing rare and fast-growing cancerous tumors, which also affects young children. This mutation ...

Retaining one normal BRCA gene in breast, ovarian cancers influences patient survival

August 22, 2017
Determining which cancer patients are likely to be resistant to initial treatment is a major research effort of oncologists and laboratory scientists. Now, ascertaining who might fall into that category may become a little ...

Study identifies miR122 target sites in liver cancer and links a gene to patient survival

August 22, 2017
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, ...

Zebrafish larvae could be used as 'avatars' to optimize personalized treatment of cancer

August 21, 2017
Portuguese scientists have for the first time shown that the larvae of a tiny fish could one day become the preferred model for predicting, in advance, the response of human malignant tumors to the various therapeutic drugs ...

Scientists discover vitamin C regulates stem cell function, curbs leukemia development

August 21, 2017
Not much is known about stem cell metabolism, but a new study from the Children's Medical Center Research Institute at UT Southwestern (CRI) has found that stem cells take up unusually high levels of vitamin C, which then ...

Searching for the 'signature' causes of BRCAness in breast cancer

August 21, 2017
Breast cancer cells with defects in the DNA damage repair-genes BRCA1 and BRCA2 have a mutational signature (a pattern of base swaps—e.g., Ts for Gs, Cs for As—throughout a genome) known in cancer genomics as "Signature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.